PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment

Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze t...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Scientific reports Ročník 6; číslo 1; s. 39296
Hlavní autoři:	Iwata, Tomoaki, Kondo, Yasuteru, Kimura, Osamu, Morosawa, Tatsuki, Fujisaka, Yasuyuki, Umetsu, Teruyuki, Kogure, Takayuki, Inoue, Jun, Nakagome, Yu, Shimosegawa, Tooru
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 14.12.2016 Nature Publishing Group
Témata:	13 13/106 13/21 13/31 692/4020/4021 692/4020/4021/1607 Aged Arsenic B7-H1 Antigen - analysis Blood Cells - chemistry Blood Cells - immunology Carcinoma, Hepatocellular - pathology Cell Count Cells, Cultured Coculture Techniques Color Female Flow Cytometry Hepatocellular carcinoma Hepatocytes Humanities and Social Sciences Humans Immunoregulation Japan Leukocytes, Mononuclear - chemistry Leukocytes, Mononuclear - immunology Liver cancer Liver Neoplasms - pathology Macrophage colony-stimulating factor Male Middle Aged multidisciplinary Myeloid-Derived Suppressor Cells - chemistry Myeloid-Derived Suppressor Cells - immunology PD-L1 protein Peripheral blood Science Suppressor cells Tumor cell lines Tumor Microenvironment Tumors
ISSN:	2045-2322, 2045-2322
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1 + MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1 + MDSCs in comparison to those from healthy subjects ( p < 0.001). The percentages of PD-L1 + MDSCs were reduced by curative treatment for HCC ( p < 0.05), and the percentages of PD-L1 + MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1 + MDSCs were significantly increased compared with control ( p < 0.05). The expression of M-CSF and VEGFA was higher in the cell lines that strongly induced PD-L1 + MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1 + MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1 + MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1 + MDSCs as a new biomarker of HCC.
AbstractList	Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1 MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1 MDSCs in comparison to those from healthy subjects (p < 0.001). The percentages of PD-L1 MDSCs were reduced by curative treatment for HCC (p < 0.05), and the percentages of PD-L1 MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1 MDSCs were significantly increased compared with control (p < 0.05). The expression of M-CSF and VEGFA was higher in the cell lines that strongly induced PD-L1 MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1 MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1 MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1 MDSCs as a new biomarker of HCC. Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1+MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1+MDSCs in comparison to those from healthy subjects (p < 0.001). The percentages of PD-L1+MDSCs were reduced by curative treatment for HCC (p < 0.05), and the percentages of PD-L1+MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1+MDSCs were significantly increased compared with control (p < 0.05). The expression of M-CSF and VEGFA was higher in the cell lines that strongly induced PD-L1+MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1+MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1+MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1+MDSCs as a new biomarker of HCC. Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1 + MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1 + MDSCs in comparison to those from healthy subjects ( p < 0.001). The percentages of PD-L1 + MDSCs were reduced by curative treatment for HCC ( p < 0.05), and the percentages of PD-L1 + MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1 + MDSCs were significantly increased compared with control ( p < 0.05). The expression of M-CSF and VEGFA was higher in the cell lines that strongly induced PD-L1 + MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1 + MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1 + MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1 + MDSCs as a new biomarker of HCC. Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1+MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1+MDSCs in comparison to those from healthy subjects (p < 0.001). The percentages of PD-L1+MDSCs were reduced by curative treatment for HCC (p < 0.05), and the percentages of PD-L1+MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1+MDSCs were significantly increased compared with control (p < 0.05). The expression of M-CSF and VEGFA was higher in the cell lines that strongly induced PD-L1+MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1+MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1+MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1+MDSCs as a new biomarker of HCC.Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors. The immune-suppressive functions of MDSCs in hepatocellular carcinoma (HCC) patients have not been clarified. Therefore, we tried to analyze the biological significance of MDSCs in HCC patients. We quantified PD-L1+MDSCs of HCC patients in various conditions by using multi-color flow cytometry analysis. PBMCs from HCC patients contained significantly higher percentages of PD-L1+MDSCs in comparison to those from healthy subjects (p < 0.001). The percentages of PD-L1+MDSCs were reduced by curative treatment for HCC (p < 0.05), and the percentages of PD-L1+MDSCs before treatment were inversely correlated with disease-free survival time. After we cocultivated PBMCs and several liver cancer cell lines in a transwell coculture system, the percentages of PD-L1+MDSCs were significantly increased compared with control (p < 0.05). The expression of M-CSF and VEGFA was higher in the cell lines that strongly induced PD-L1+MDSCs. Peripheral blood from HCC patients had significantly higher percentages of PD-L1+MDSCs in comparison to those of healthy subjects, and the percentages of PD-L1+MDSCs were reduced by HCC treatment, suggesting that we might use PD-L1+MDSCs as a new biomarker of HCC.
ArticleNumber	39296
Author	Kogure, Takayuki Nakagome, Yu Shimosegawa, Tooru Iwata, Tomoaki Kondo, Yasuteru Kimura, Osamu Morosawa, Tatsuki Fujisaka, Yasuyuki Inoue, Jun Umetsu, Teruyuki
Author_xml	– sequence: 1 givenname: Tomoaki surname: Iwata fullname: Iwata, Tomoaki organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 2 givenname: Yasuteru surname: Kondo fullname: Kondo, Yasuteru organization: Division of Gastroenterology, Tohoku University Hospital, Department of Hepatology, Sendai Kousei Hospital – sequence: 3 givenname: Osamu surname: Kimura fullname: Kimura, Osamu organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 4 givenname: Tatsuki surname: Morosawa fullname: Morosawa, Tatsuki organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 5 givenname: Yasuyuki surname: Fujisaka fullname: Fujisaka, Yasuyuki organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 6 givenname: Teruyuki surname: Umetsu fullname: Umetsu, Teruyuki organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 7 givenname: Takayuki surname: Kogure fullname: Kogure, Takayuki organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 8 givenname: Jun surname: Inoue fullname: Inoue, Jun organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 9 givenname: Yu surname: Nakagome fullname: Nakagome, Yu organization: Division of Gastroenterology, Tohoku University Hospital – sequence: 10 givenname: Tooru surname: Shimosegawa fullname: Shimosegawa, Tooru organization: Division of Gastroenterology, Tohoku University Hospital
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27966626$$D View this record in MEDLINE/PubMed
BookMark	eNptkU1v1DAQhi3UipbSA38AReJSQKH-jOMLUpUCRVoEEnC2bGfSukrsxU4q9d_j1bbVtuCLx55nXr-eeYH2QgyA0CuCPxDM2tOcYM0UVc0zdEgxFzVllO7txAfoOOdrXJagihP1HB1QqZqmoc0hgh_n9Yq8_3b-s8uVSVD54BKYDH2Jqouuq9Zm9hDmkg2bu35xJWdvqxzHxY5QDcbNMW3o-QqqeZnKYfIuRQg3PsUwleKXaH8wY4bju_0I_f786Vd3Ua--f_nana1qJzCfa4ZxzylIwjgeqOtd41hjwVLhqOXtYBVntleCYSM5bmUrYFAEGFgQgxwcO0Ift7rrxU7Qu_J0MqNeJz-ZdKuj8fpxJvgrfRlvtCBCUE6LwMmdQIp_Fsiznnx2MI4mQFyyJq2gjVRYyYK-eYJexyWF8r1CKcUko5IV6vWuowcr9xMowOkWKB3LZZaDdn4uLY8bg37UBOvNmPXDmEvF2ycV96L_Y99t2VyYcAlpx-Q_8F8sObah
CitedBy_id	crossref_primary_10_1007_s00005_018_0531_9 crossref_primary_10_3389_fimmu_2020_01299 crossref_primary_10_3390_biomedicines6030087 crossref_primary_10_3389_fimmu_2024_1400112 crossref_primary_10_1155_2020_6527192 crossref_primary_10_1080_2162402X_2018_1494113 crossref_primary_10_1186_s40164_024_00543_1 crossref_primary_10_3389_fimmu_2021_638841 crossref_primary_10_1016_j_intimp_2022_108628 crossref_primary_10_1038_s41598_021_90515_w crossref_primary_10_3389_fonc_2020_00165 crossref_primary_10_4103_ejcrp_eJCRP_D_22_00033 crossref_primary_10_1080_2162402X_2022_2043037 crossref_primary_10_1038_s41598_022_07770_8 crossref_primary_10_1002_cac2_12156 crossref_primary_10_1007_s00262_019_02427_4 crossref_primary_10_1097_MS9_0000000000002126 crossref_primary_10_3389_fonc_2022_911961 crossref_primary_10_1186_s13045_024_01544_7 crossref_primary_10_3390_biomedicines12020299 crossref_primary_10_3390_cells8121647 crossref_primary_10_7554_eLife_95009 crossref_primary_10_3390_ijms22105123 crossref_primary_10_1089_ars_2022_0047 crossref_primary_10_3389_fimmu_2020_01371 crossref_primary_10_3390_vaccines13050496 crossref_primary_10_3389_fimmu_2019_00949 crossref_primary_10_1038_s41598_025_01335_1 crossref_primary_10_1016_j_pharmr_2025_100074 crossref_primary_10_1016_j_jddst_2024_106589 crossref_primary_10_1371_journal_pone_0225327 crossref_primary_10_1111_sji_13312 crossref_primary_10_3389_fimmu_2021_816499 crossref_primary_10_3390_cancers12092495 crossref_primary_10_1371_journal_pone_0291455 crossref_primary_10_3390_ijms241512086 crossref_primary_10_1016_j_cellimm_2020_104280 crossref_primary_10_3390_ijms22115736 crossref_primary_10_1002_hsr2_202 crossref_primary_10_1177_17534259231215581 crossref_primary_10_3389_fonc_2020_610104 crossref_primary_10_1080_10408363_2018_1477729 crossref_primary_10_1186_s12967_020_02389_7 crossref_primary_10_3389_fonc_2021_699546 crossref_primary_10_1002_mco2_447 crossref_primary_10_3390_cancers15061661 crossref_primary_10_1016_j_nantod_2021_101163 crossref_primary_10_3390_biomedicines9010090 crossref_primary_10_1002_hep_30036 crossref_primary_10_3389_fimmu_2022_781660 crossref_primary_10_1186_s12943_019_1047_6 crossref_primary_10_3390_cancers13205127 crossref_primary_10_1007_s12094_020_02390_y crossref_primary_10_1159_000531225 crossref_primary_10_1016_j_lfs_2022_120755 crossref_primary_10_1038_s41416_018_0333_1 crossref_primary_10_1186_s12885_019_5471_1 crossref_primary_10_1038_s41598_019_49706_9 crossref_primary_10_1016_j_intimp_2025_114693 crossref_primary_10_3389_fimmu_2023_1323581 crossref_primary_10_1002_adhm_202302013 crossref_primary_10_2217_fon_2020_0162 crossref_primary_10_1007_s00005_023_00681_0 crossref_primary_10_1038_s41598_022_21472_1 crossref_primary_10_1016_j_smim_2022_101668 crossref_primary_10_3390_biology12070999 crossref_primary_10_4049_jimmunol_1800129 crossref_primary_10_1016_j_cellimm_2021_104317 crossref_primary_10_1038_s41571_023_00846_y crossref_primary_10_4251_wjgo_v16_i5_1690 crossref_primary_10_1080_14737140_2022_2011224 crossref_primary_10_3390_jcm10081768 crossref_primary_10_3389_fimmu_2023_1133308
Cites_doi	10.1002/jmv.20194 10.1016/bs.acr.2015.04.002 10.1158/0008-5472.can-07-6621 10.1007/s00262-012-1294-5 10.1016/S1470-2045(01)00486-7 10.1016/j.intimp.2014.12.024 10.1016/j.bpg.2014.07.018 10.3978/j.issn.2218-6751.2015.06.05 10.3978/j.issn.2218-6751.2015.06.07 10.4049/jimmunol.0712671 10.1007/s00262-013-1447-1 10.3748/wjg.v13.i44.5944 10.1086/596739 10.1111/hepr.12167 10.1038/nrc3239 10.1111/ddg.12819 10.4049/jimmunol.0900092 10.3748/wjg.v12.i27.4310 10.1002/hep.27328 10.1016/j.it.2013.07.003 10.1016/S1535-6108(04)00058-3 10.1016/j.intimp.2009.03.021 10.1056/NEJMoa1200690 10.1002/hep.22626 10.3390/ijms16023307 10.1038/nri2506 10.1038/srep28814 10.1097/MCG.0b013e3182872f29 10.1038/nri2326 10.1016/j.molimm.2008.08.266 10.1084/jem.20131916 10.1007/s00262-015-1736-y 10.3748/wjg.v21.i1.94 10.1128/jvi.00716-15 10.1038/nri1703 10.1086/653496 10.1172/jci80005 10.1084/jem.20082173 10.14348/molcells.2014.2282 10.1007/s10555-011-9280-5 10.1158/0008-5472.can-07-6229 10.1158/0008-5472.can-14-2371 10.1128/JVI.00716-15
ContentType	Journal Article
Copyright	The Author(s) 2016 Copyright Nature Publishing Group Dec 2016 Copyright © 2016, The Author(s) 2016 The Author(s)
Copyright_xml	– notice: The Author(s) 2016 – notice: Copyright Nature Publishing Group Dec 2016 – notice: Copyright © 2016, The Author(s) 2016 The Author(s)
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM
DOI	10.1038/srep39296
DatabaseName	SpringerOpen CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE CrossRef MEDLINE - Academic Publicly Available Content Database
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2045-2322
ExternalDocumentID	PMC5155242 27966626 10_1038_srep39296
Genre	Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS EJD ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM
ID	FETCH-LOGICAL-c504t-300d42e71340f2cdc6c36beb25c2b48fb943bd9530a7408785ef91e3ebe5f7fc3
IEDL.DBID	M7P
ISICitedReferencesCount	79
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000389741800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2045-2322
IngestDate	Tue Nov 04 02:01:06 EST 2025 Sun Nov 09 10:30:26 EST 2025 Tue Oct 07 06:58:36 EDT 2025 Mon Jul 21 05:41:59 EDT 2025 Tue Nov 18 21:59:20 EST 2025 Sat Nov 29 06:11:29 EST 2025 Fri Feb 21 02:38:34 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c504t-300d42e71340f2cdc6c36beb25c2b48fb943bd9530a7408785ef91e3ebe5f7fc3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work.
OpenAccessLink	https://www.proquest.com/docview/1899373273?pq-origsite=%requestingapplication%
PMID	27966626
PQID	1899373273
PQPubID	2041939
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5155242 proquest_miscellaneous_1852679097 proquest_journals_1899373273 pubmed_primary_27966626 crossref_citationtrail_10_1038_srep39296 crossref_primary_10_1038_srep39296 springer_journals_10_1038_srep39296
PublicationCentury	2000
PublicationDate	2016-12-14
PublicationDateYYYYMMDD	2016-12-14
PublicationDate_xml	– month: 12 year: 2016 text: 2016-12-14 day: 14
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Scientific reports
PublicationTitleAbbrev	Sci Rep
PublicationTitleAlternate	Sci Rep
PublicationYear	2016
Publisher	Nature Publishing Group UK Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group UK – name: Nature Publishing Group
References	Mittal, El-Serag (CR4) 2013; 47 Serafini, Mgebroff, Noonan, Borrello (CR21) 2008; 68 Topalian (CR37) 2012; 366 Carrizosa, Gold (CR39) 2015; 4 Kondo, Shimosegawa (CR9) 2015; 16 Dumitriu, Dunbar, Howie, Sethi, Gregory (CR22) 2009; 182 Pardoll (CR35) 2012; 12 Bruix, Boix, Sala, Llovet (CR2) 2004; 5 Shen, Wang, He, Wang, Zheng (CR29) 2014; 44 Chatterjee, Mitra (CR3) 2015; 24 Parker, Beury, Ostrand-Rosenberg (CR33) 2015; 128 CR10 Rich, Singal (CR25) 2014; 28 Gabrilovich, Nagaraj (CR26) 2009; 9 Kondo (CR11) 2010; 202 Kondo, Kimura, Shimosegawa (CR24) 2015; 21 Shoji (CR32) 2016; 6 Bak, Alonso, Turk, Berwin (CR17) 2008; 46 Preisser (CR31) 2014; 60 Li, Sun, Chen, Wei, Tian (CR43) 2015; 75 Kondo (CR14) 2004; 74 Kondo (CR12) 2009; 199 Noman (CR42) 2014; 211 Arihara (CR30) 2013; 62 Medina-Echeverz, Eggert, Han, Greten (CR41) 2015; 64 Parkin (CR1) 2001; 2 Sheng, Zhang (CR8) 2007; 13 Stewart, Smyth (CR15) 2011; 30 Kuang (CR28) 2009; 206 Kondo (CR13) 2006; 12 Nagaraj, Gabrilovich (CR18) 2008; 68 Zeng (CR27) 2014; 37 Derman, Mileham, Bonomi, Batus, Fidler (CR40) 2015; 4 Palmer (CR7) 2009; 49 Corzo (CR19) 2009; 182 Wieder, Brenner, Braumuller, Rocken (CR38) 2016; 14 Karin, Greten (CR5) 2005; 5 Zou, Chen (CR23) 2008; 8 Marvel, Gabrilovich (CR34) 2015; 125 Kondo (CR6) 2015; 89 Ceeraz, Nowak, Noelle (CR36) 2013; 34 Donkor (CR20) 2009; 9 Dumitru, Moses, Trellakis, Lang, Brandau (CR16) 2012; 61 Y Kondo (BFsrep39296_CR9) 2015; 16 DM Parkin (BFsrep39296_CR1) 2001; 2 Y Kondo (BFsrep39296_CR11) 2010; 202 XL Sheng (BFsrep39296_CR8) 2007; 13 IE Dumitriu (BFsrep39296_CR22) 2009; 182 Y Kondo (BFsrep39296_CR6) 2015; 89 TJ Stewart (BFsrep39296_CR15) 2011; 30 S Nagaraj (BFsrep39296_CR18) 2008; 68 M Karin (BFsrep39296_CR5) 2005; 5 Y Kondo (BFsrep39296_CR24) 2015; 21 MK Donkor (BFsrep39296_CR20) 2009; 9 DM Kuang (BFsrep39296_CR28) 2009; 206 BA Derman (BFsrep39296_CR40) 2015; 4 DM Pardoll (BFsrep39296_CR35) 2012; 12 CA Corzo (BFsrep39296_CR19) 2009; 182 W Zou (BFsrep39296_CR23) 2008; 8 F Arihara (BFsrep39296_CR30) 2013; 62 QL Zeng (BFsrep39296_CR27) 2014; 37 Y Kondo (BFsrep39296_CR12) 2009; 199 CA Dumitru (BFsrep39296_CR16) 2012; 61 J Bruix (BFsrep39296_CR2) 2004; 5 D Marvel (BFsrep39296_CR34) 2015; 125 T Wieder (BFsrep39296_CR38) 2016; 14 R Chatterjee (BFsrep39296_CR3) 2015; 24 KH Parker (BFsrep39296_CR33) 2015; 128 P Shen (BFsrep39296_CR29) 2014; 44 BFsrep39296_CR10 SL Topalian (BFsrep39296_CR37) 2012; 366 Y Kondo (BFsrep39296_CR14) 2004; 74 Y Kondo (BFsrep39296_CR13) 2006; 12 J Medina-Echeverz (BFsrep39296_CR41) 2015; 64 L Preisser (BFsrep39296_CR31) 2014; 60 MZ Noman (BFsrep39296_CR42) 2014; 211 SP Bak (BFsrep39296_CR17) 2008; 46 N Rich (BFsrep39296_CR25) 2014; 28 H Shoji (BFsrep39296_CR32) 2016; 6 S Li (BFsrep39296_CR43) 2015; 75 S Mittal (BFsrep39296_CR4) 2013; 47 DH Palmer (BFsrep39296_CR7) 2009; 49 S Ceeraz (BFsrep39296_CR36) 2013; 34 P Serafini (BFsrep39296_CR21) 2008; 68 DI Gabrilovich (BFsrep39296_CR26) 2009; 9 DR Carrizosa (BFsrep39296_CR39) 2015; 4 19451266 - J Exp Med. 2009 Jun 8;206(6):1327-37 23764929 - Cancer Immunol Immunother. 2013 Aug;62(8):1421-30 18824264 - Mol Immunol. 2008 Dec;46(2):258-68 17990361 - World J Gastroenterol. 2007 Nov 28;13(44):5944-50 18500231 - Nat Rev Immunol. 2008 Jun;8(6):467-77 18980227 - Hepatology. 2009 Jan;49(1):124-32 19380816 - J Immunol. 2009 May 1;182(9):5693-701 25574082 - World J Gastroenterol. 2015 Jan 7;21(1):94-101 22658127 - N Engl J Med. 2012 Jun 28;366(26):2443-54 11905707 - Lancet Oncol. 2001 Sep;2(9):533-43 18593947 - Cancer Res. 2008 Jul 1;68(13):5439-49 23632345 - J Clin Gastroenterol. 2013 Jul;47 Suppl:S2-6 26629421 - Transl Lung Cancer Res. 2015 Oct;4(5):524-32 26168215 - J Clin Invest. 2015 Sep;125(9):3356-64 16865771 - World J Gastroenterol. 2006 Jul 21;12(27):4310-7 26629424 - Transl Lung Cancer Res. 2015 Oct;4(5):553-9 23701406 - Hepatol Res. 2014 Jun;44(6):639-50 26713633 - J Dtsch Dermatol Ges. 2016 Jan;14(1):28-37 24778419 - J Exp Med. 2014 May 5;211(5):781-90 25560752 - Int Immunopharmacol. 2015 Feb;24(2):335-45 18413722 - Cancer Res. 2008 Apr 15;68(8):2561-3 19197294 - Nat Rev Immunol. 2009 Mar;9(3):162-74 16175180 - Nat Rev Immunol. 2005 Oct;5(10):749-59 25926643 - J Virol. 2015 Jul;89(14):7016-27 25260312 - Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53 19234174 - J Immunol. 2009 Mar 1;182(5):2795-807 15368520 - J Med Virol. 2004 Nov;74(3):425-33 24552712 - Mol Cells. 2014 Jan;37(1):66-73 27363523 - Sci Rep. 2016 Jul 01;6:28814 26133122 - Cancer Immunol Immunother. 2015 Aug;64(8):931-40 15050913 - Cancer Cell. 2004 Mar;5(3):215-9 22692756 - Cancer Immunol Immunother. 2012 Aug;61(8):1155-67 25066464 - Hepatology. 2014 Dec;60(6):1879-90 21249424 - Cancer Metastasis Rev. 2011 Mar;30(1):125-40 25654227 - Int J Mol Sci. 2015 Feb 03;16(2):3307-22 19199548 - J Infect Dis. 2009 Mar 1;199(5):726-36 23954143 - Trends Immunol. 2013 Nov;34(11):556-63 19362167 - Int Immunopharmacol. 2009 Jul;9(7-8):937-48 25600646 - Cancer Res. 2015 Mar 15;75(6):986-95 26216631 - Adv Cancer Res. 2015;128:95-139 22437870 - Nat Rev Cancer. 2012 Mar 22;12(4):252-64 20533879 - J Infect Dis. 2010 Jul 15;202(2):202-13
References_xml	– volume: 74 start-page: 425 year: 2004 end-page: 433 ident: CR14 article-title: Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity publication-title: Journal of medical virology doi: 10.1002/jmv.20194 – volume: 128 start-page: 95 year: 2015 end-page: 139 ident: CR33 article-title: Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment publication-title: Advances in cancer research doi: 10.1016/bs.acr.2015.04.002 – volume: 68 start-page: 5439 year: 2008 end-page: 5449 ident: CR21 article-title: Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells publication-title: Cancer Res doi: 10.1158/0008-5472.can-07-6621 – volume: 61 start-page: 1155 year: 2012 end-page: 1167 ident: CR16 article-title: Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-012-1294-5 – volume: 2 start-page: 533 year: 2001 end-page: 543 ident: CR1 article-title: Global cancer statistics in the year 2000 publication-title: The Lancet Oncology doi: 10.1016/S1470-2045(01)00486-7 – volume: 24 start-page: 335 year: 2015 end-page: 345 ident: CR3 article-title: An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer publication-title: International Immunopharmacology doi: 10.1016/j.intimp.2014.12.024 – volume: 28 start-page: 843 year: 2014 end-page: 853 ident: CR25 article-title: Hepatocellular carcinoma tumour markers: current role and expectations publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2014.07.018 – ident: CR10 – volume: 4 start-page: 553 year: 2015 end-page: 559 ident: CR39 article-title: New strategies in immunotherapy for non-small cell lung cancer publication-title: Translational lung cancer research doi: 10.3978/j.issn.2218-6751.2015.06.05 – volume: 4 start-page: 524 year: 2015 end-page: 532 ident: CR40 article-title: Treatment of advanced squamous cell carcinoma of the lung: a review publication-title: Translational lung cancer research doi: 10.3978/j.issn.2218-6751.2015.06.07 – volume: 182 start-page: 2795 year: 2009 end-page: 2807 ident: CR22 article-title: Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+regulatory T cells publication-title: Journal of immunology (Baltimore, Md.: 1950) doi: 10.4049/jimmunol.0712671 – volume: 62 start-page: 1421 year: 2013 end-page: 1430 ident: CR30 article-title: Increase in CD14 + HLA-DR −/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-013-1447-1 – volume: 13 start-page: 5944 year: 2007 end-page: 5950 ident: CR8 article-title: activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells publication-title: World journal of gastroenterology: WJG doi: 10.3748/wjg.v13.i44.5944 – volume: 199 start-page: 726 year: 2009 end-page: 736 ident: CR12 article-title: Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6 publication-title: The Journal of infectious diseases doi: 10.1086/596739 – volume: 44 start-page: 639 year: 2014 end-page: 650 ident: CR29 article-title: Increased circulating Lin(−/low) CD33(+) HLA-DR(−) myeloid-derived suppressor cells in hepatocellular carcinoma patients publication-title: Hepatol Res doi: 10.1111/hepr.12167 – volume: 12 start-page: 252 year: 2012 end-page: 264 ident: CR35 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nature reviews. Cancer doi: 10.1038/nrc3239 – volume: 14 start-page: 28 year: 2016 end-page: 36 ident: CR38 article-title: Immunotherapy of melanoma: efficacy and mode of action publication-title: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG doi: 10.1111/ddg.12819 – volume: 182 start-page: 5693 year: 2009 end-page: 5701 ident: CR19 article-title: Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells publication-title: Journal of immunology (Baltimore, Md.: 1950) doi: 10.4049/jimmunol.0900092 – volume: 12 start-page: 4310 year: 2006 end-page: 4317 ident: CR13 article-title: Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B publication-title: World journal of gastroenterology: WJG doi: 10.3748/wjg.v12.i27.4310 – volume: 60 start-page: 1879 year: 2014 end-page: 1890 ident: CR31 article-title: IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells publication-title: Hepatology doi: 10.1002/hep.27328 – volume: 34 start-page: 556 year: 2013 end-page: 563 ident: CR36 article-title: B7 family checkpoint regulators in immune regulation and disease publication-title: Trends in immunology doi: 10.1016/j.it.2013.07.003 – volume: 5 start-page: 215 year: 2004 end-page: 219 ident: CR2 article-title: Focus on hepatocellular carcinoma publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00058-3 – volume: 9 start-page: 937 year: 2009 end-page: 948 ident: CR20 article-title: Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2009.03.021 – volume: 366 start-page: 2443 year: 2012 end-page: 2454 ident: CR37 article-title: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer publication-title: The New England journal of medicine doi: 10.1056/NEJMoa1200690 – volume: 49 start-page: 124 year: 2009 end-page: 132 ident: CR7 article-title: A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.22626 – volume: 16 start-page: 3307 year: 2015 end-page: 3322 ident: CR9 article-title: Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs publication-title: Int J Mol Sci doi: 10.3390/ijms16023307 – volume: 9 start-page: 162 year: 2009 end-page: 174 ident: CR26 article-title: Myeloid-derived suppressor cells as regulators of the immune system publication-title: Nature reviews. Immunology doi: 10.1038/nri2506 – volume: 6 start-page: 28814 year: 2016 ident: CR32 article-title: Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease publication-title: Scientific reports doi: 10.1038/srep28814 – volume: 47 start-page: S2 year: 2013 end-page: 6 ident: CR4 article-title: Epidemiology of hepatocellular carcinoma: consider the population publication-title: Journal of clinical gastroenterology doi: 10.1097/MCG.0b013e3182872f29 – volume: 8 start-page: 467 year: 2008 end-page: 477 ident: CR23 article-title: Inhibitory B7-family molecules in the tumour microenvironment publication-title: Nature reviews. Immunology doi: 10.1038/nri2326 – volume: 46 start-page: 258 year: 2008 end-page: 268 ident: CR17 article-title: Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression publication-title: Molecular immunology doi: 10.1016/j.molimm.2008.08.266 – volume: 211 start-page: 781 year: 2014 end-page: 790 ident: CR42 article-title: PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation publication-title: The Journal of experimental medicine doi: 10.1084/jem.20131916 – volume: 64 start-page: 931 year: 2015 end-page: 940 ident: CR41 article-title: Hepatic myeloid-derived suppressor cells in cancer publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-015-1736-y – volume: 21 start-page: 94 year: 2015 end-page: 101 ident: CR24 article-title: Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma publication-title: World journal of gastroenterology: WJG doi: 10.3748/wjg.v21.i1.94 – volume: 89 start-page: 7016 year: 2015 end-page: 7027 ident: CR6 article-title: Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells publication-title: Journal of virology doi: 10.1128/jvi.00716-15 – volume: 5 start-page: 749 year: 2005 end-page: 759 ident: CR5 article-title: NF-kappaB: linking inflammation and immunity to cancer development and progression publication-title: Nature reviews. Immunology doi: 10.1038/nri1703 – volume: 202 start-page: 202 year: 2010 end-page: 213 ident: CR11 article-title: Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes publication-title: The Journal of infectious diseases doi: 10.1086/653496 – volume: 125 start-page: 3356 year: 2015 end-page: 3364 ident: CR34 article-title: Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected publication-title: The Journal of clinical investigation doi: 10.1172/jci80005 – volume: 206 start-page: 1327 year: 2009 end-page: 1337 ident: CR28 article-title: Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 publication-title: The Journal of experimental medicine doi: 10.1084/jem.20082173 – volume: 37 start-page: 66 year: 2014 end-page: 73 ident: CR27 article-title: Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR zeta chain expression on CD8(+) T cells in chronic hepatitis C patients publication-title: Molecules and cells doi: 10.14348/molcells.2014.2282 – volume: 30 start-page: 125 year: 2011 end-page: 140 ident: CR15 article-title: Improving cancer immunotherapy by targeting tumor-induced immune suppression publication-title: Cancer metastasis reviews doi: 10.1007/s10555-011-9280-5 – volume: 68 start-page: 2561 year: 2008 end-page: 2563 ident: CR18 article-title: Tumor escape mechanism governed by myeloid-derived suppressor cells publication-title: Cancer Res doi: 10.1158/0008-5472.can-07-6229 – volume: 75 start-page: 986 year: 2015 end-page: 995 ident: CR43 article-title: TLR2 Limits Development of Hepatocellular Carcinoma by Reducing IL18-Mediated Immunosuppression publication-title: Cancer Res doi: 10.1158/0008-5472.can-14-2371 – volume: 8 start-page: 467 year: 2008 ident: BFsrep39296_CR23 publication-title: Nature reviews. Immunology doi: 10.1038/nri2326 – volume: 47 start-page: S2 year: 2013 ident: BFsrep39296_CR4 publication-title: Journal of clinical gastroenterology doi: 10.1097/MCG.0b013e3182872f29 – volume: 202 start-page: 202 year: 2010 ident: BFsrep39296_CR11 publication-title: The Journal of infectious diseases doi: 10.1086/653496 – volume: 211 start-page: 781 year: 2014 ident: BFsrep39296_CR42 publication-title: The Journal of experimental medicine doi: 10.1084/jem.20131916 – volume: 74 start-page: 425 year: 2004 ident: BFsrep39296_CR14 publication-title: Journal of medical virology doi: 10.1002/jmv.20194 – volume: 49 start-page: 124 year: 2009 ident: BFsrep39296_CR7 publication-title: Hepatology doi: 10.1002/hep.22626 – volume: 68 start-page: 5439 year: 2008 ident: BFsrep39296_CR21 publication-title: Cancer Res doi: 10.1158/0008-5472.can-07-6621 – volume: 2 start-page: 533 year: 2001 ident: BFsrep39296_CR1 publication-title: The Lancet Oncology doi: 10.1016/S1470-2045(01)00486-7 – volume: 4 start-page: 524 year: 2015 ident: BFsrep39296_CR40 publication-title: Translational lung cancer research doi: 10.3978/j.issn.2218-6751.2015.06.07 – volume: 5 start-page: 749 year: 2005 ident: BFsrep39296_CR5 publication-title: Nature reviews. Immunology doi: 10.1038/nri1703 – volume: 75 start-page: 986 year: 2015 ident: BFsrep39296_CR43 publication-title: Cancer Res doi: 10.1158/0008-5472.can-14-2371 – volume: 16 start-page: 3307 year: 2015 ident: BFsrep39296_CR9 publication-title: Int J Mol Sci doi: 10.3390/ijms16023307 – volume: 9 start-page: 162 year: 2009 ident: BFsrep39296_CR26 publication-title: Nature reviews. Immunology doi: 10.1038/nri2506 – volume: 366 start-page: 2443 year: 2012 ident: BFsrep39296_CR37 publication-title: The New England journal of medicine doi: 10.1056/NEJMoa1200690 – volume: 68 start-page: 2561 year: 2008 ident: BFsrep39296_CR18 publication-title: Cancer Res doi: 10.1158/0008-5472.can-07-6229 – volume: 125 start-page: 3356 year: 2015 ident: BFsrep39296_CR34 publication-title: The Journal of clinical investigation doi: 10.1172/jci80005 – volume: 13 start-page: 5944 year: 2007 ident: BFsrep39296_CR8 publication-title: World journal of gastroenterology: WJG doi: 10.3748/wjg.v13.i44.5944 – volume: 37 start-page: 66 year: 2014 ident: BFsrep39296_CR27 publication-title: Molecules and cells doi: 10.14348/molcells.2014.2282 – volume: 206 start-page: 1327 year: 2009 ident: BFsrep39296_CR28 publication-title: The Journal of experimental medicine doi: 10.1084/jem.20082173 – volume: 60 start-page: 1879 year: 2014 ident: BFsrep39296_CR31 publication-title: Hepatology doi: 10.1002/hep.27328 – volume: 128 start-page: 95 year: 2015 ident: BFsrep39296_CR33 publication-title: Advances in cancer research doi: 10.1016/bs.acr.2015.04.002 – volume: 24 start-page: 335 year: 2015 ident: BFsrep39296_CR3 publication-title: International Immunopharmacology doi: 10.1016/j.intimp.2014.12.024 – volume: 9 start-page: 937 year: 2009 ident: BFsrep39296_CR20 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2009.03.021 – volume: 21 start-page: 94 year: 2015 ident: BFsrep39296_CR24 publication-title: World journal of gastroenterology: WJG doi: 10.3748/wjg.v21.i1.94 – volume: 14 start-page: 28 year: 2016 ident: BFsrep39296_CR38 publication-title: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG doi: 10.1111/ddg.12819 – ident: BFsrep39296_CR10 doi: 10.1128/JVI.00716-15 – volume: 44 start-page: 639 year: 2014 ident: BFsrep39296_CR29 publication-title: Hepatol Res doi: 10.1111/hepr.12167 – volume: 182 start-page: 2795 year: 2009 ident: BFsrep39296_CR22 publication-title: Journal of immunology (Baltimore, Md.: 1950) doi: 10.4049/jimmunol.0712671 – volume: 89 start-page: 7016 year: 2015 ident: BFsrep39296_CR6 publication-title: Journal of virology doi: 10.1128/jvi.00716-15 – volume: 12 start-page: 4310 year: 2006 ident: BFsrep39296_CR13 publication-title: World journal of gastroenterology: WJG doi: 10.3748/wjg.v12.i27.4310 – volume: 199 start-page: 726 year: 2009 ident: BFsrep39296_CR12 publication-title: The Journal of infectious diseases doi: 10.1086/596739 – volume: 12 start-page: 252 year: 2012 ident: BFsrep39296_CR35 publication-title: Nature reviews. Cancer doi: 10.1038/nrc3239 – volume: 6 start-page: 28814 year: 2016 ident: BFsrep39296_CR32 publication-title: Scientific reports doi: 10.1038/srep28814 – volume: 4 start-page: 553 year: 2015 ident: BFsrep39296_CR39 publication-title: Translational lung cancer research doi: 10.3978/j.issn.2218-6751.2015.06.05 – volume: 64 start-page: 931 year: 2015 ident: BFsrep39296_CR41 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-015-1736-y – volume: 61 start-page: 1155 year: 2012 ident: BFsrep39296_CR16 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-012-1294-5 – volume: 34 start-page: 556 year: 2013 ident: BFsrep39296_CR36 publication-title: Trends in immunology doi: 10.1016/j.it.2013.07.003 – volume: 46 start-page: 258 year: 2008 ident: BFsrep39296_CR17 publication-title: Molecular immunology doi: 10.1016/j.molimm.2008.08.266 – volume: 182 start-page: 5693 year: 2009 ident: BFsrep39296_CR19 publication-title: Journal of immunology (Baltimore, Md.: 1950) doi: 10.4049/jimmunol.0900092 – volume: 5 start-page: 215 year: 2004 ident: BFsrep39296_CR2 publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00058-3 – volume: 28 start-page: 843 year: 2014 ident: BFsrep39296_CR25 publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2014.07.018 – volume: 62 start-page: 1421 year: 2013 ident: BFsrep39296_CR30 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-013-1447-1 – volume: 30 start-page: 125 year: 2011 ident: BFsrep39296_CR15 publication-title: Cancer metastasis reviews doi: 10.1007/s10555-011-9280-5 – reference: 27363523 - Sci Rep. 2016 Jul 01;6:28814 – reference: 19380816 - J Immunol. 2009 May 1;182(9):5693-701 – reference: 25260312 - Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53 – reference: 23701406 - Hepatol Res. 2014 Jun;44(6):639-50 – reference: 21249424 - Cancer Metastasis Rev. 2011 Mar;30(1):125-40 – reference: 23954143 - Trends Immunol. 2013 Nov;34(11):556-63 – reference: 17990361 - World J Gastroenterol. 2007 Nov 28;13(44):5944-50 – reference: 25926643 - J Virol. 2015 Jul;89(14):7016-27 – reference: 25654227 - Int J Mol Sci. 2015 Feb 03;16(2):3307-22 – reference: 18593947 - Cancer Res. 2008 Jul 1;68(13):5439-49 – reference: 15368520 - J Med Virol. 2004 Nov;74(3):425-33 – reference: 18413722 - Cancer Res. 2008 Apr 15;68(8):2561-3 – reference: 19234174 - J Immunol. 2009 Mar 1;182(5):2795-807 – reference: 20533879 - J Infect Dis. 2010 Jul 15;202(2):202-13 – reference: 25600646 - Cancer Res. 2015 Mar 15;75(6):986-95 – reference: 11905707 - Lancet Oncol. 2001 Sep;2(9):533-43 – reference: 19451266 - J Exp Med. 2009 Jun 8;206(6):1327-37 – reference: 22692756 - Cancer Immunol Immunother. 2012 Aug;61(8):1155-67 – reference: 16865771 - World J Gastroenterol. 2006 Jul 21;12(27):4310-7 – reference: 26216631 - Adv Cancer Res. 2015;128:95-139 – reference: 26713633 - J Dtsch Dermatol Ges. 2016 Jan;14(1):28-37 – reference: 25574082 - World J Gastroenterol. 2015 Jan 7;21(1):94-101 – reference: 26168215 - J Clin Invest. 2015 Sep;125(9):3356-64 – reference: 19199548 - J Infect Dis. 2009 Mar 1;199(5):726-36 – reference: 25066464 - Hepatology. 2014 Dec;60(6):1879-90 – reference: 18500231 - Nat Rev Immunol. 2008 Jun;8(6):467-77 – reference: 22437870 - Nat Rev Cancer. 2012 Mar 22;12(4):252-64 – reference: 23764929 - Cancer Immunol Immunother. 2013 Aug;62(8):1421-30 – reference: 23632345 - J Clin Gastroenterol. 2013 Jul;47 Suppl:S2-6 – reference: 24552712 - Mol Cells. 2014 Jan;37(1):66-73 – reference: 22658127 - N Engl J Med. 2012 Jun 28;366(26):2443-54 – reference: 16175180 - Nat Rev Immunol. 2005 Oct;5(10):749-59 – reference: 19197294 - Nat Rev Immunol. 2009 Mar;9(3):162-74 – reference: 25560752 - Int Immunopharmacol. 2015 Feb;24(2):335-45 – reference: 26629421 - Transl Lung Cancer Res. 2015 Oct;4(5):524-32 – reference: 24778419 - J Exp Med. 2014 May 5;211(5):781-90 – reference: 26133122 - Cancer Immunol Immunother. 2015 Aug;64(8):931-40 – reference: 19362167 - Int Immunopharmacol. 2009 Jul;9(7-8):937-48 – reference: 18980227 - Hepatology. 2009 Jan;49(1):124-32 – reference: 26629424 - Transl Lung Cancer Res. 2015 Oct;4(5):553-9 – reference: 15050913 - Cancer Cell. 2004 Mar;5(3):215-9 – reference: 18824264 - Mol Immunol. 2008 Dec;46(2):258-68
SSID	ssj0000529419
Score	2.4768841
Snippet	Myeloid-derived suppressor cells (MDSCs) could have important roles in immune regulation, and MDSCs can be induced in patients with various malignant tumors....
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	39296
SubjectTerms	13 13/106 13/21 13/31 692/4020/4021 692/4020/4021/1607 Aged Arsenic B7-H1 Antigen - analysis Blood Cells - chemistry Blood Cells - immunology Carcinoma, Hepatocellular - pathology Cell Count Cells, Cultured Coculture Techniques Color Female Flow Cytometry Hepatocellular carcinoma Hepatocytes Humanities and Social Sciences Humans Immunoregulation Japan Leukocytes, Mononuclear - chemistry Leukocytes, Mononuclear - immunology Liver cancer Liver Neoplasms - pathology Macrophage colony-stimulating factor Male Middle Aged multidisciplinary Myeloid-Derived Suppressor Cells - chemistry Myeloid-Derived Suppressor Cells - immunology PD-L1 protein Peripheral blood Science Suppressor cells Tumor cell lines Tumor Microenvironment Tumors
Title	PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment
URI	https://link.springer.com/article/10.1038/srep39296 https://www.ncbi.nlm.nih.gov/pubmed/27966626 https://www.proquest.com/docview/1899373273 https://www.proquest.com/docview/1852679097 https://pubmed.ncbi.nlm.nih.gov/PMC5155242
Volume	6
WOSCitedRecordID	wos000389741800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB6apIVe-k7rNl3Ux6FQTGRLtqRTaTcJKXQX0wdsT8bWgy4k3u16t5B_X41fzSall16E7RnwwIw0I81oPoDXhdPKe4EiVHHEQ85cERZlIkPGbOKkNorqFmxCTKdyNlNZd-BWd2WV_ZrYLNRmofGM_DCS6EmZ97bvlj9DRI3C7GoHobEDe9glgTWle9lwxoJZLB6pvqEQk4fe7SwxIki33dC12PJ6ieSVPGnjfk7u_q_g9-BOF3iS962l3IcbtnoAt1ooyouHYLOj8FP0dnL0ZVyTYmXJvMJ4srbGP5HT8Zh0HVg9tcJvxtuEIeUFQeMtzyxpkXuQ28eUZL059y_nWO536S7dI_h2cvx1fBp2EAyhTihfh4xSw2OLF06pi7XRqWZp6XfjiY5LLl2pOCuNShgtBKdSyMQ6FVnmTSNxwmm2D7vVorJPgETGSmfSNFaScm850jhTcuwuz4z2S24Ab3qN5LrrT44wGWd5kydnMh-UF8DLgXXZNuX4G9NBr4-8m5d1_kcZAbwYyH5GYZqkqOxigzxJnApFlQjgcWsFw19i4beHfg8YgNiyj4EBu3VvU6r5j6ZrN2Lp-HgogFe9JV0S66rwT_8t_DO47QO3BkAp4gewu15t7HO4qX-t5_VqBDtiJppRjmDvw_E0-zxqzhr8OImzUTNJPCX7OMm-_wZEcBuM
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwED-NARovfA8CA8zHJCQULbGdxH5ACLVMndZVlRjS3kLiD1FpS0vTgvpP8TdyzhfrhnjbA29JfErs-M535zvfD-BNZpVELZD5kobc58xmfpZHwmfMRFYoLQNVg00ko5E4OZHjDfjVnoVxaZXtmlgt1Hqq3B75XiicJmWobT_MvvsONcpFV1sIjZotDs3qJ7ps5fuDPs7vLqX7n457A79BFfBVFPCFz4JAc2rcGcrAUqVVrFico4MZKZpzYXPJWa5lxIIs4YFIRGSsDA3D0UY2sYrhe6_BdTQjqKhSBcfdno6LmvFQtgWMmNhDNTdzFki8rvYu2bKXUzIvxGUrdbd_53_7UXfhdmNYk4-1JNyDDVPch5s11ObqAZhx3x-G7476n3slyeaGTApnL5dG4xUZ9HqkqTCLrYV7ppHnNclXxAlnfmpIjUzkqNFmJovlGd6cuXTGc2cFH8KXKxnjNmwW08I8BhJqI6yOYypFwFEyhLY65656PtMKVYoHb1sOSFVTf93BgJymVR4AE2nHLB686khnddGRvxHttPOfNutOmf6ZfA9eds24YrgwUFaY6dLRRDROZCATDx7VXNd9hSbo_qKP60Gyxo8dgatGvt5STL5VVckdVhDaex68bjn3XLcudv7Jvzv_ArYGx0fDdHgwOnwKt9BIrcCiQr4Dm4v50jyDG-rHYlLOn1cCSODrVTPyb7T4cj0
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEB6VcogX7iNQwByVkFC0Sewk9gNCaJdVq5bVSoDUt5D4ECu12WUP0P41fh0zuei2iLc-8JbEo8RJvvHM2OP5AF7lTiu0ArmvolD4grvcz4tY-pzb2EltVKBrsol0NJJHR2q8Bb_avTCUVtmOidVAbaaa5sh7oSRLytHa9lyTFjEeDN_NvvvEIEUrrS2dRg2RA7v-ieHb4u3-AP_1bhQNP3zu7_kNw4Cv40AsfR4ERkSW9lMGLtJGJ5onBQabsY4KIV2hBC-MinmQpyKQqYytU6Hl-OaxS53meN9LcDmlouVV2uC4m9-hFTQRqraYEZc9NHkz8kaSTRN4zq89n555Zo22Mn3Dm__zR7sFNxqHm72vNeQ2bNnyDlytKTjXd8GOB_5h-Obj4FN_wfK5ZZOS_OiFNXjE9vp91lSexdaSrhnUBcOKNSOlLY4tqxmLSBp9abZcneDJCaU5ntpDeA--XMg73oftclrah8BCY6UzSRIpGQjUGGmcKQRV1edGo6nx4HWLhkw3ddmJHuQ4q_IDuMw64HjwohOd1cVI_ia002Iha8ajRfYHCB4875pxJKHloby00xXJxFGSqkClHjyoEdg9JUoxLMbY14N0A5udAFUp32wpJ9-qauXEIYR-oAcvWxSf6tbZzj_6d-efwTXEb3a4Pzp4DNfRd604pEKxA9vL-co-gSv6x3KymD-tdJHB14vG8W98nnr6
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PD-L1%2BMDSCs+are+increased+in+HCC+patients+and+induced+by+soluble+factor+in+the+tumor+microenvironment&rft.jtitle=Scientific+reports&rft.au=Iwata%2C+Tomoaki&rft.au=Kondo%2C+Yasuteru&rft.au=Kimura%2C+Osamu&rft.au=Morosawa%2C+Tatsuki&rft.date=2016-12-14&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=6&rft.spage=39296&rft_id=info:doi/10.1038%2Fsrep39296&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon